About opioid dependence and addiction

Description: 
A reference tool used to provide clinicians with stabilization resources for substance use disorder within active duty and veteran populations, including resources on pharmacological treatment and substance titration.
Source: 
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders
field_vote: 
Resource Type: 
Description: 
The Legal Action Center’s MAT Advocacy Toolkit can help you fight for your right to medication-assisted treatment (MAT) for opioid addiction. MAT involves the use of medications, such as methadone, buprenorphine/naloxone (Suboxone) and injectable naltrexone (Vivitrol), in combination with counseling. Dozens of studies have shown that MAT reduces illicit drug use, crime, and communicable disease. Yet courts, probation, parole, and child welfare officials often force people to stop MAT against their doctor’s recommendation.
Source: 
Legal Action Center
field_vote: 

Pharmacy Consent Form for Buprenorphine Treatment

Description: 
By signing this Appointed Pharmacy Consent Form, the patient authorizes a provider to disclose to the pharmacy that he or she is being treated for opioid dependence; the pharmacy is also authorized to contact the provider to discuss treatment.

Name/Practice Name: ____________________________
Address: _____________________________________________
Address: _____________________________________________
City, State, ZIP: ________________________________________
Phone: _______________________________________________
Fax: _________________________________________________

APPOINTED PHARMACY CONSENT

I, ______________________________________________[Patient Name- Print], do hereby:

(MD check all that apply)

field_vote: 
Commonly Used Forms: 
Resource Type: 

DSM 5 Criteria for Opioid Withdrawal

Description: 
Lists the DSM 5 Criteria for Opioid Withdrawal (APA, 2013).

Opioid withdrawal occurs in opioid-dependent individuals who reduce or stop their opioid use or who take an opioid antagonist (precipitated withdrawal). Because of its high affinity but low activity at opioid receptors, buprenorphine can act as an antagonist in some patients.

DSM 5 Criteria for Opioid Withdrawal

field_vote: 
Tags: 

Pages

Subscribe to About opioid dependence and addiction